A decrease in cyclin B1 levels leads to polyploidization in DNA damage-induced senescence

Cell Biology International

Volumn 34, Issue 6, 2010, Pages 645-653

  Kikuchi, Ikue ^a   Nakayama, Yuji ^a   Morinaga, Takao ^a   Fukumoto, Yasunori ^a   Yamaguchi, Naoto ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

galactosidase; Adriamycin; Cyclin B1; Fluorescein D galactopyranoside; Polyploidy; Senescence

Indexed keywords

BETA GALACTOSIDASE; CYCLIN B1; DOXORUBICIN; ANTINEOPLASTIC ANTIBIOTIC;

ARTICLE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL SHAPE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOSE RESPONSE; ENZYME ACTIVITY; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; POLYPLOIDY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; DRUG EFFECT; METABOLISM;

ANTIBIOTICS, ANTINEOPLASTIC; BETA-GALACTOSIDASE; CELL AGING; CYCLIN B1; DNA DAMAGE; DOXORUBICIN; HELA CELLS; HUMANS; POLYPLOIDY;

EID: 77955079457     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090398     Document Type: Article

References (53)

1. Badie C, Itzhaki JE, Sullivan MJ, Carpenter AJ, Porter ACG. Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G2/M arrest in human cells. Moll Cell Biol 2000;20:2358-66.
2. Biton S, Dar I, Mittelman L, Pereg Y, Barzilai A, Shiloh Y. Nuclear ataxia-telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells. J Biol Chem 2006;281:17482-91.
3. Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. γH2AX and cancer. Nature Rev Cancer 2008;8:957-67.
4. Brown JM, Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 1999;59:1391-9.
5. Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel ES, Lausch E, Christov K, Roninson IB. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 1999;59:3761-7.
6. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007;130:223-33.
7. Crawford DF, Piwnica-Worms H. The G2 DNA damage checkpoint delays expression of genes encoding mitotic regulators. J Biol Chem 2001;276:37166-77.
8. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNAdamage response. Nature Rev Cancer 2008;8:512-22.
9. Diffley, JFX. Regulation of early events in chromosome replication. Curr Biol 2004;14:R778-86.
10. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-7.
11. Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma. Cancer Lett 2002;177:13-9.
12. Dutta A, Chandra R, Leiter LM, Lester S. Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc Natl Acad Sci USA 1995;92:5386-90.
13. Edgar BA, Orr-Weaver TL. Endoreplication cell cycles: more for less. Cell 2001;105:297-306.
14. Eom YW, Kim MA, Park SS, Goo MJ, Kwon HJ, Sohn S, Kim WH, Yoon G, Choi KS. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 2005;24:4765-77.
15. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin. Biochem Pharmacol 1999;57:727-41.
16. Grabsch H, Lickvers K, Hansen O, Takeno S, Willers R, Stock W, Gabbert HE, Mueller W. Prognostic value of cyclin B1 protein expression in colorectal cancer. Am J Clin Pathol 2004;122:511-6.
17. Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, Sedivy J, Hendrickson EA, Balan KV, Pantazis P, Wyche JH. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 2002;277:17154-60.
18. Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK, Mao L. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res 2001;7:2458-62.
19. 2-induced senescence without affecting telomerase enzymatic activity. Biochem Biophys Res Commun 2003;301:627-32.
20. Jackson JG, Pereira-Smith OM. Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol Cell Biol 2006;26:2501-10.
21. Kahlem P, Dörken B, Schmitt CA. Cellular senescence in cancer treatment: friend or foe? J Clin Invest 2004;113:169-74.
22. Kasahara K, Nakayama Y, Ikeda K, Fukushima Y, Matsuda D, Horimoto S, Yamaguchi N. Trafficking of Lyn through the Golgi caveolin involves the charged residues on alphaE and alphaI helices in the kinase domain. J Cell Biol 2004;165:641-52.
23. Kops GJPL, Weaver BAA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nature Rev Cancer 2005;5:773-85.
24. Kushner J, Bradley G, Young B, Jordan RC. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J Oral Pathol Med 1999;28:77-81.
25. Li JQ, Kubo A, Wu F, Usuki H, Fujita J, Bandoh S, Masaki T, Saoo K, Takeuchi H, Kobayashi S, Imaida K, Maeta H, Ishida T, Kuriyama S. Cyclin B1, unlike cyclin G1, increases significantly during colorectal carcinogenesis and during later metastasis to lymph nodes. Int J Oncol 2003;22:1101-10.
26. Maity A, Hwang A, Janss A, Phillips P, McKenna WG, Muschel RJ. Delayed cyclin B1 expression during the G2 arrest following DNA damage. Oncogene 1996;13:1647-57.
27. Maity A, McKenna WG, Muschel RJ. Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J 1995;14:603-9.
28. Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ, Dutta A. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res 1996;56:4159-63.
29. Matsuda D, Nakayama Y, Horimoto S, Kuga T, Ikeda K, Kasahara K, Yamaguchi N. Involvement of Golgi-associated Lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress. Exp Cell Res 2006;312:1205-17.
30. McCrann DJ, Nguyen HG, Jones MR, Ravid K. Vascular smooth muscle cell polyploidy: an adaptive or maladaptive response? J Cell Physiol 2008;215:588-92.
31. Michishita E, Matsumura N, Kurahashi T, Suzuki T, Ogino H, Fujii M, Ayusawa D. 5-Halogenated thymidine analogues induce a senescence-like phenomenon in HeLa cells. Biosci Biotechnol Biochem 2002;66:877-9.
32. Murakami H, Furihata M, Ohtsuki Y, Ogoshi S. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 1999;434:153-8.
33. Nakayama Y, Igarashi A, Kikuchi I, Obata Y, Fukumoto Y, Yamaguchi N. Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway. Exp Cell Res 2009;315:2515-28.
34. Nakayama Y, Kawana A, Igarashi A, Yamaguchi N. Involvement of the Nterminal unique domain of Chk tyrosine kinase in Chk-induced tyrosine phosphorylation in the nucleus. Exp Cell Res 2006;312:2252-63.
35. Nakayama Y, Yamaguchi N. Multi-lobulation of the nucleus in prolonged S phase by nuclear expression of Chk tyrosine kinase. Exp Cell Res 2005;304:570-81.
36. Nolan GP, Fiering S, Nicolas JF, Herzenberg LA. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-Dgalactosidase activity after transduction of Escherichia coli lacZ. Proc Natl Acad Sci USA 1988;85:2603-7.
37. Nurse P. Universal control mechanism regulating onset of M-phase. Nature 1990;344:503-8.
38. Ohi R, Gould KL. Regulating the onset of mitosis. Curr Opin Cell Biol 1999;11:267-73.
39. Park SS, Eom YW, Choi KS. Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis. Biochem Biophys Res Commun 2005;334:1014-21.
40. Peters JM. The anaphase-promoting complex: Proteolysis in mitosis and beyond. Mol Cell 2002;9:931-43.
41. cdc2. Cell 1989;58:833-46.
42. Rebbaa A, Zheng X, Chou PM, Mirkin BL. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 2003;22:2805-11.
43. Roberson RS, Kussick SJ, Vallieres E, Chen SYJ, Wu DY. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res 2005;65:2795-803.
44. Roninson IB. Tumor cell senescence in cancer treatment. Cancer Res 2003;63:2705-15.
45. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
46. Sliwinska MA, Mosieniak G, Wolanin K, Babik A, Piwocka K, Magalska A, Szczepanowska J, Fronk J, Sikora E. Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells. Mech Ageing Dev 2009;130:24-32.
47. Song Y, Zhao C, Dong L, Fu M, Xue L, Huang Z, Tong T, Zhou Z, Chen A, Yang Z, Lu N, Zhan Q. Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Carcinogenesis 2008;29:307-15.
48. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 2000;60:4000-4.
49. Suzuki T, Michishita E, Ogino H, Fujii M, Ayusawa D. Synergistic induction of the senescence-associated genes by 5-bromodeoxyuridine and AT-binding ligands in HeLa cells. Exp Cell Res 2002;276:174-84.
50. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Müller W. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 2002;94:2874-81.
51. Wagner M, Hampel B, Bernhard D, Hala M, Zwerschke W, Jansen-Dürr P. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol 2001;36:1327-47.
52. Yang D, McCrann DJ, Nguyen H, St Hilaire C, DePinho RA, Jones MR, Ravid K. Increased polyploidy in aortic vascular smooth muscle cells during aging is marked by cellular senescence. Aging Cell 2007;6:257-60.
53. Yasuda M, Takesue F, Inutsuka S, Honda M, Nozoe T, Korenaga D. Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study. J Cancer Res Clin Oncol 2002;128:412-6.